Transphorm, Inc.

2024 Q1 Form 10-Q Financial Statement

#000171576824000009 Filed on February 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.951M $23.15M
YoY Change -65.65% -42.8%
Cash & Equivalents $8.000M $23.15M
Short-Term Investments
Other Short-Term Assets $1.275M $2.070M
YoY Change -38.41% 18.35%
Inventory $10.01M $7.476M
Prepaid Expenses
Receivables $1.721M $3.704M
Other Receivables $0.00 $0.00
Total Short-Term Assets $20.95M $36.40M
YoY Change -42.44% -28.15%
LONG-TERM ASSETS
Property, Plant & Equipment $7.679M $5.367M
YoY Change 43.08% 182.92%
Goodwill $1.020M $1.097M
YoY Change -7.02% -12.24%
Intangibles
YoY Change
Long-Term Investments $0.00 $647.0K
YoY Change -100.0% 960.66%
Other Assets $601.0K $2.167M
YoY Change -72.27% 668.44%
Total Long-Term Assets $11.71M $12.85M
YoY Change -8.84% 207.25%
TOTAL ASSETS
Total Short-Term Assets $20.95M $36.40M
Total Long-Term Assets $11.71M $12.85M
Total Assets $32.66M $49.25M
YoY Change -33.67% -10.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.232M $4.016M
YoY Change 5.38% -15.43%
Accrued Expenses $5.074M $2.193M
YoY Change 131.37% 77.0%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $12.00M
YoY Change -100.0%
Long-Term Debt Due $0.00 $184.0K
YoY Change -100.0% -50.0%
Total Short-Term Liabilities $12.41M $18.39M
YoY Change -32.53% 177.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $2.670M
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $2.670M
YoY Change -100.0% -77.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.41M $18.39M
Total Long-Term Liabilities $0.00 $2.670M
Total Liabilities $14.41M $21.06M
YoY Change -31.58% 13.1%
SHAREHOLDERS EQUITY
Retained Earnings -$242.1M -$200.4M
YoY Change 20.78% 15.44%
Common Stock $6.000K $6.000K
YoY Change 0.0% 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.25M $28.18M
YoY Change
Total Liabilities & Shareholders Equity $32.66M $49.25M
YoY Change -33.67% -10.21%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57047013 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
262319000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242146000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1929000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18250000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32662000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4670000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-502000 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Transphorm, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1858829
dei Entity Address Address Line1
EntityAddressAddressLine1
75 Castilian Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Goleta,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93117
dei City Area Code
CityAreaCode
805
dei Local Phone Number
LocalPhoneNumber
456-1300
dei Trading Symbol
TradingSymbol
TGAN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7951000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001715768
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
63266180 shares
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
263000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1721000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
4396000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
10005000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
8406000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
20952000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
30688000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7679000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7890000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2311000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3033000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1020000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
1079000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
99000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
321000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
715000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
601000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
726000 usd
CY2023Q4 us-gaap Assets
Assets
32662000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9306000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7895000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63195948 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63195948 shares
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4493000 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
4595000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
7162000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
-2669000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2839000 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1745000 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1447000 usd
CY2023Q4 us-gaap Costs And Expenses
CostsAndExpenses
8996000 usd
CY2022Q4 us-gaap Costs And Expenses
CostsAndExpenses
7229000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8921000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-9898000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
0 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
184000 usd
CY2023Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-978000 usd
CY2022Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-799000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-102000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
421000 usd
CY2023Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-10001000 usd
CY2022Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-10460000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10001000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-10460000 usd
CY2023Q4 tgan Deemed Dividend Related To Warrant Modification And Issuance Of Inducement Warrants
DeemedDividendRelatedToWarrantModificationAndIssuanceOfInducementWarrants
2721000 usd
CY2022Q4 tgan Deemed Dividend Related To Warrant Modification And Issuance Of Inducement Warrants
DeemedDividendRelatedToWarrantModificationAndIssuanceOfInducementWarrants
0 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12722000 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12722000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32910000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62183843 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62183843 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56739450 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56739450 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61458945 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61458945 shares
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10001000 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
211000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
211000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
521000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18250000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7951000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21800000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15527000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1275000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1859000 usd
CY2023Q1 us-gaap Assets
Assets
44452000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
180000 usd
CY2023Q4 tgan Unfunded Commitment In Joint Venture Current
UnfundedCommitmentInJointVentureCurrent
1296000 usd
CY2023Q1 tgan Unfunded Commitment In Joint Venture Current
UnfundedCommitmentInJointVentureCurrent
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1430000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1458000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
368000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
404000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
12000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12410000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
21937000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2002000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2670000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
230000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
14412000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
24837000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57047013 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
230272000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-209236000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1427000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
19615000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44452000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15563000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13319000 usd
us-gaap Cost Of Revenue
CostOfRevenue
12226000 usd
us-gaap Cost Of Revenue
CostOfRevenue
14444000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
75000 usd
us-gaap Gross Profit
GrossProfit
3337000 usd
us-gaap Gross Profit
GrossProfit
-1125000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2325000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8730000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5895000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4935000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3596000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4412000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3457000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11870000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9818000 usd
us-gaap Costs And Expenses
CostsAndExpenses
25535000 usd
us-gaap Costs And Expenses
CostsAndExpenses
19309000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22198000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-20434000 usd
us-gaap Interest Expense
InterestExpense
8000 usd
us-gaap Interest Expense
InterestExpense
550000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2559000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2065000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
188000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1241000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-24577000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-21808000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-24577000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21808000 usd
tgan Deemed Dividend Related To Warrant Modification And Issuance Of Inducement Warrants
DeemedDividendRelatedToWarrantModificationAndIssuanceOfInducementWarrants
8333000 usd
tgan Deemed Dividend Related To Warrant Modification And Issuance Of Inducement Warrants
DeemedDividendRelatedToWarrantModificationAndIssuanceOfInducementWarrants
0 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10460000 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10460000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-32910000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21808000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21808000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55926828 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55926828 shares
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-10460000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24577000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21808000 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
521000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-502000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-136000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-136000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9790000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9939000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25079000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21944000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
23691000 usd
CY2023Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
86000 usd
CY2023Q4 tgan Stock Issued During Period Value Warrant Exercises And Deemed Dividend
StockIssuedDuringPeriodValueWarrantExercisesAndDeemedDividend
2926000 usd
CY2023Q4 tgan Adjustments To Additional Paid In Capital Deemed Dividend Related To Warrants Issued
AdjustmentsToAdditionalPaidInCapitalDeemedDividendRelatedToWarrantsIssued
0 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1509000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
211000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10001000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
36345000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
653000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1123000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
521000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-10460000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
28182000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
19615000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
374000 usd
tgan Stock Issued During Period Value Warrant Exercises And Deemed Dividend
StockIssuedDuringPeriodValueWarrantExercisesAndDeemedDividend
10094000 usd
tgan Adjustments To Additional Paid In Capital Deemed Dividend Related To Warrants Issued
AdjustmentsToAdditionalPaidInCapitalDeemedDividendRelatedToWarrantsIssued
0 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9569000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4425000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-502000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24577000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18250000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
31361000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
709000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15720000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2342000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-136000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21808000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
28182000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24577000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21808000 usd
us-gaap Inventory Write Down
InventoryWriteDown
332000 usd
us-gaap Inventory Write Down
InventoryWriteDown
2810000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
913000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
719000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
396000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
425000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
263000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
208000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4425000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2342000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
4000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
48000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
110000 usd
tgan Gain Loss On Joint Ventures
GainLossOnJointVentures
-2559000 usd
tgan Gain Loss On Joint Ventures
GainLossOnJointVentures
-2065000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-169000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-75000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2404000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1221000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2047000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3956000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-613000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-401000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-146000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
504000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
300000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
428000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-346000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-20000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
486000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-406000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-392000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14360000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18582000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
623000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5633000 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
48000 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
110000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
807000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
2569000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1382000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8092000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
709000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9936000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16000000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
123000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
280000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
374000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
10257000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
12000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7696000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16423000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-30000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-35000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8076000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10286000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16027000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33935000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23649000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7951000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23149000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
500000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7951000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23649000 usd
us-gaap Interest Paid Net
InterestPaidNet
188000 usd
us-gaap Interest Paid Net
InterestPaidNet
546000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
185000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
tgan Stock Warrant Exercise And Deemed Dividend Related To Warrant Modification
StockWarrantExerciseAndDeemedDividendRelatedToWarrantModification
1590000 usd
tgan Stock Warrant Exercise And Deemed Dividend Related To Warrant Modification
StockWarrantExerciseAndDeemedDividendRelatedToWarrantModification
0 usd
tgan Deemed Dividend Related To Issuance Of Inducement Warrants
DeemedDividendRelatedToIssuanceOfInducementWarrants
6743000 usd
tgan Deemed Dividend Related To Issuance Of Inducement Warrants
DeemedDividendRelatedToIssuanceOfInducementWarrants
0 usd
tgan Rights Offering Costs Accrued
RightsOfferingCostsAccrued
409000 usd
tgan Rights Offering Costs Accrued
RightsOfferingCostsAccrued
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3598000 usd
tgan Operating Lease Right Of Use Assets And Liability For Lease Modification
OperatingLeaseRightOfUseAssetsAndLiabilityForLeaseModification
-300000 usd
tgan Operating Lease Right Of Use Assets And Liability For Lease Modification
OperatingLeaseRightOfUseAssetsAndLiabilityForLeaseModification
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-24600000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14400000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18600000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242100000 usd
CY2023Q4 tgan Working Capital
WorkingCapital
8500000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10001000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-10460000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24577000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21808000 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12722000 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12722000 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10460000 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10460000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32910000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-32910000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21808000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21808000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62183843 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62183843 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56739450 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56739450 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61458945 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61458945 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55926828 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55926828 shares
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4776610 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3366373 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2481914 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3146131 shares
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4670000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4493000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15563000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13319000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4669000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5167000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2181000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1719000 usd
CY2023Q4 tgan Inventory Sub Assembly Net Of Reserves
InventorySubAssemblyNetOfReserves
2083000 usd
CY2023Q1 tgan Inventory Sub Assembly Net Of Reserves
InventorySubAssemblyNetOfReserves
809000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1072000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
711000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
10005000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
8406000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23719000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23601000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16040000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15711000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7679000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7890000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
200000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
200000 usd
us-gaap Depreciation
Depreciation
700000 usd
us-gaap Depreciation
Depreciation
500000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5224000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4951000 usd
CY2023Q4 tgan Finite Lived Intangible Assets Accumulated Change In Foreign Exchange Rate
FiniteLivedIntangibleAssetsAccumulatedChangeInForeignExchangeRate
174000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
99000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5224000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4729000 usd
CY2023Q1 tgan Finite Lived Intangible Assets Accumulated Change In Foreign Exchange Rate
FiniteLivedIntangibleAssetsAccumulatedChangeInForeignExchangeRate
174000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
321000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
74000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
25000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
99000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
1180000 usd
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-101000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
1079000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-59000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1020000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4232000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2781000 usd
CY2023Q4 tgan Accrued Manufacturing Production Costs Current
AccruedManufacturingProductionCostsCurrent
1017000 usd
CY2023Q1 tgan Accrued Manufacturing Production Costs Current
AccruedManufacturingProductionCostsCurrent
506000 usd
CY2023Q4 tgan Accrued Legal Fees Current
AccruedLegalFeesCurrent
842000 usd
CY2023Q1 tgan Accrued Legal Fees Current
AccruedLegalFeesCurrent
596000 usd
CY2023Q4 tgan Accrued Audit Fees Current
AccruedAuditFeesCurrent
50000 usd
CY2023Q1 tgan Accrued Audit Fees Current
AccruedAuditFeesCurrent
318000 usd
CY2023Q4 tgan Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
209000 usd
CY2023Q1 tgan Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
256000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
221000 usd
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
76000 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0 usd
CY2023Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
2950000 usd
CY2023Q4 tgan Equipment Sale Buyback Liability Current
EquipmentSaleBuybackLiabilityCurrent
2100000 usd
CY2023Q1 tgan Equipment Sale Buyback Liability Current
EquipmentSaleBuybackLiabilityCurrent
0 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
635000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
412000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5074000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5114000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9306000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7895000 usd
CY2021Q3 tgan Variable Interest Entity Maximum Loss Exposure Term
VariableInterestEntityMaximumLossExposureTerm
P3Y
CY2023Q4 tgan Variable Interest Entity Amount Provided
VariableInterestEntityAmountProvided
6100000 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
8000 usd
CY2022Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
200000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
600000 usd
CY2023Q4 tgan Equipment Purchase And Sale Consideration
EquipmentPurchaseAndSaleConsideration
2100000 usd
CY2023Q4 tgan Equipment Purchase And Sale Option To Repurchase Period
EquipmentPurchaseAndSaleOptionToRepurchasePeriod
P1Y
CY2023Q4 tgan Equipment Purchase And Sale Percentage Of Purchase Price
EquipmentPurchaseAndSalePercentageOfPurchasePrice
0.075
CY2023Q4 tgan Equipment Purchase And Sale Repurchase Option Fee
EquipmentPurchaseAndSaleRepurchaseOptionFee
157500 usd
CY2023Q4 tgan Equipment Purchase And Sale Percentage Of Purchase Price
EquipmentPurchaseAndSalePercentageOfPurchasePrice
0.075
CY2023Q4 tgan Equipment Sale Buyback Liability Current
EquipmentSaleBuybackLiabilityCurrent
2100000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63195948 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63195948 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 tgan Common Stock Voting Rights Number
CommonStockVotingRightsNumber
1 vote
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15127311 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4027929 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3323966 shares
tgan Class Of Warrant Or Right Warrants Issued
ClassOfWarrantOrRightWarrantsIssued
3589083 shares
tgan Class Of Warrant Or Right Warrants Exercised
ClassOfWarrantOrRightWarrantsExercised
2885120 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4027929 shares
CY2023Q3 tgan Number Of Non Transferable Subscription Right
NumberOfNonTransferableSubscriptionRight
1 subscription_right
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
500000 usd
CY2022Q4 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
4 segment
CY2023Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1700 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-200000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
7000 usd
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001715768-24-000009-index-headers.html Edgar Link pending
0001715768-24-000009-index.html Edgar Link pending
0001715768-24-000009.txt Edgar Link pending
0001715768-24-000009-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tgan-20231231.htm Edgar Link pending
tgan-20231231.xsd Edgar Link pending
tgan-20231231_g1.jpg Edgar Link pending
tgan-outsidedirectorcompen.htm Edgar Link pending
tganex31112312023ceocertif.htm Edgar Link pending
tganex31212312023cfocertif.htm Edgar Link pending
tganex32112312023ceocfocer.htm Edgar Link pending
tgan-20231231_def.xml Edgar Link unprocessable
tgan-20231231_lab.xml Edgar Link unprocessable
tgan-20231231_pre.xml Edgar Link unprocessable
tgan-20231231_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
tgan-20231231_cal.xml Edgar Link unprocessable